期刊文献+

甲状腺相关疾病中IGF-1及其受体的表达及意义 被引量:3

Expression and Significance of IGF-1 and IGF-1R in Thyroid Related Diseases
下载PDF
导出
摘要 胰岛素样生长因子1(IGF-1)是一种具有促进物质代谢和细胞分裂等功能的细胞增殖调控因子,主要由肝脏产生,通过自分泌和(或)旁分泌的方式发挥作用。IGF-1参与了正常细胞增殖、凋亡以及器官的生长和发育过程,且与肿瘤的形成、发展、侵入和转移密切相关。近年来有研究表明,IGF-1与其受体(IGF-1R)在甲状腺相关疾病的发生和发展中起到了重要的作用,故可能成为临床治疗新的靶点。 Insulin-like growth factor 1( IGF-1),a kind of cell proliferation regulatory factor,can promote metabolism and cellular fission. IGF-1 is mainly produced by the liver,and plays its role through autocrine and / or paracrine. IGF-1 is not only involved in normal cell proliferation,apoptosis,and growth and development of organs,but also closely related to tumor formation,development,invasion and metastasis. In recent years,studies have shown that IGF-1 and IGF-1 receptor( IGF-1R) play an important role in thyroid-related diseases,which may become a potential target for clinical treatment.
出处 《医学综述》 2015年第3期409-411,共3页 Medical Recapitulate
关键词 胰岛素样生长因子1 胰岛素样生长因子1受体 甲状腺功能 甲状腺结节 甲状腺相关眼病 Insulin-like growth factor 1 Insulin-like growth factor 1 receptor Thyroid function Thyroid nodule Thyroid associated ophthalmopathy
  • 相关文献

参考文献39

  • 1Salmon WD Jr,Daughaday WH.A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro[J].J Lab Clin Med,1957,49(6):825-836.
  • 2Liu YJ,Qiang W,Liu XJ,et al.Association of insulin-like growth factor-1 with thyroid nodules[J].Oncol Lett,2011,2(6):1297-1301.
  • 3Xian L,Wu X,Pang L,et al.Matrix IGF-1 maintains bone mass by activation of m TOR in mesenchymal stem cells[J].Nat Med,2012,18(7):1095-1101.
  • 4Liu YJ,Qiang W,Shi J,et al.Expression and significance of IGF-1and IGF-1R in thyroid nodules[J].Endocrine,2013,44(1):158-164.
  • 5Conti E,Musumeci MB,De Giusti M,et al.IGF-1 and atherothrombosis:relevance to pathophysiology and therapy[J].Clin Sci(Lond),2011,120(9):377-402.
  • 6Balhara B,Misra M,Levitsky LL.Recombinant human IGF-1(insulin-like growth factor)therapy:where do we stand today?[J].Indian J Pediatr,2012,79(2):244-249.
  • 7Junnila RK,List EO,Berryman DE,et al.The GH/IGF-1 axis in ageing and longevity[J].Nat Rev Endocrinol,2013,9(6):366-376.
  • 8Fidan Yaylali G,Akin F,Turgut S,et al.IGF-1 gene polymorphism in obese patients with insulin resistance[J].Mol Biol Rep,2010,37(1):529-533.
  • 9Castellano G,Affuso F,Conza PD,et al.The GH/IGF-1 Axis and Heart Failure[J].Curr Cardiol Rev,2009,5(3):203-215.
  • 10Ni F,Sun R,Fu B,et al.IGF-1 promotes the development and cytotoxic activity of human NK cells[J].Nat Commun,2013,4:1479.

二级参考文献15

  • 1Jazbec J, Ecimovic P, Jereb B. Second neoplasms after treatment of childhood cancer in Slovenia [ J ]. Pediatr Blood Cancer, 2004, 42(7):574-581.
  • 2Teng W, Shah Z, Teng X, et al. Effect of iodine intake on thyroid diseases in China[J]. N Engl J Med, 2006. 354 (26):2783-2793.
  • 3Erdogan MF, Gursoy A, Erdogan G. Natural course of benign thyroid nodules in a moderately iodine-deficient area [J ]. Clin Endocrinol (Oxf), 2006,65(6):767-771.
  • 4Gozu HI, Bircan R, Krohn K,et al. Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thymroid nodules in geographical regions with different iodine supply in Turkey [J ]. Eur J Endocrinol,2006,155(4):535-545.
  • 5Eszlinger M, Krohn K, Kratzssh J, Voigt C. Paschke R. Growth foutor expression in eold and hot thyroid nodules [J]. Thyroid, 2001, 11(2): 125-135.
  • 6Seipioni A, Ferretti E, Soda G, et al. hNIS protein in thyroid: the iodine supply influences its expression and localization [ J ]. Thyroid,2007,17(7):613-618.
  • 7Tallstedt L . Orbital disease after radioactive iodine therapy. In: Dutton JJ, ed. Thyroid eye disease. New York: Marcel Dekker, 2003. 243-249.
  • 8Bahn RS. Pathophysiology of Graves' ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab,2003, 88:1939-1946.
  • 9Scott M, Graham MD, Christopher L, et al. Medial and lateral orbital wall surgery for balanced decompression in thyroid eye disease. Laryngoscope, 2003, 113: 1206-1209.
  • 10江昌新,方佩华,张丽辉,谭郁彬.天津市20年甲状腺疾病发病的变化——天津医科大学总医院临床病理资料分析[J].中华内分泌代谢杂志,1999,15(5):275-278. 被引量:34

共引文献107

同被引文献25

引证文献3

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部